Fidelity Investments’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.2M Sell
2,535,724
-976,660
-28% -$13.4M ﹤0.01% 1561
2025
Q4
$48.5M Sell
3,512,384
-5,543,678
-61% -$130M ﹤0.01% 1458
2025
Q3
$221M Buy
9,056,062
+167,320
+2% +$4.07M 0.01% 797
2025
Q2
$205M Buy
8,888,742
+4,670
+0.1% +$123K 0.01% 809
2025
Q1
$240M Buy
8,884,072
+214,131
+2% +$8.07M 0.02% 731
2024
Q4
$464M Buy
8,669,941
+845,266
+11% +$44.7M 0.03% 498
2024
Q3
$355M Buy
7,824,675
+47,075
+0.6% +$2.05M 0.02% 601
2024
Q2
$326M Buy
7,777,600
+28,591
+0.4% +$1.34M 0.02% 608
2024
Q1
$292M Buy
7,749,009
+3,077,796
+66% +$67M 0.02% 635
2023
Q4
$50.1M Sell
4,671,213
-1,680,109
-26% -$14.5M ﹤0.01% 1290
2023
Q3
$64M Buy
6,351,322
+1,288,526
+25% +$14.9M 0.01% 1158
2023
Q2
$60.1M Sell
5,062,796
-77,848
-2% -$1.04M 0.01% 1206
2023
Q1
$62.2M Sell
5,140,644
-465,216
-8% -$7.74M 0.01% 1171
2022
Q4
$73.8M Sell
5,605,860
-641,532
-10% -$9.39M 0.01% 1088
2022
Q3
$84.6M Buy
6,247,392
+421,688
+7% +$5.63M 0.01% 1018
2022
Q2
$71.1M Buy
5,825,704
+148,778
+3% +$1.76M 0.01% 1104
2022
Q1
$81.4M Buy
5,676,926
+685,524
+14% +$11.2M 0.01% 1164
2021
Q4
$98.5M Buy
4,991,402
+1,375,971
+38% +$28.8M 0.01% 1111
2021
Q3
$78.2M Buy
3,615,431
+1,771,867
+96% +$51M 0.01% 1212
2021
Q2
$46M Buy
+1,843,564
New +$41.1M ﹤0.01% 1471

Other funds holding JANX